Daniele Rigamonti,M.D., Chief Executive Officer, (CEO)

Daniele Rigamonti, MD, FACS, took up the role of JHAH CEO in November 2016. He had previously served as the organization’s Chief of Staff (Medical), a legacy of his time as Chief of Staff are the strong relationships between clinicians at JHAH and their counterparts at Johns Hopkins Medicine in Baltimore, U.S.

Before joining JHAH, Rigamonti had spent more than 20 years with Johns Hopkins, having served as Professor of Neurosurgery, Oncology, Radiation Oncology and Molecular Radiation Sciences, and Radiology and Radiological Science, and as Director of the Department of Neurosurgery’s Stereotactic Radiosurgery, Hydrocephalus and Pseudotumor Cerebri Programs. Rigamonti is also an accomplished clinician-researcher, with nearly 200 published articles and two published books.